South Korea grants approval for Celltrion’s COVID-19 antibody treatment

On Feb 5, 2021

South Korea on Friday granted conditional approval to Celltrion Inc’s COVID-19 antibody treatment, drug safety minister Kim Gang-lip told a news conference.

The ministry has decided to authorize the drug under the condition of submission of the third clinical trial results, Kim said. The antibody drug is the first locally made coronavirus treatment in the country to win such approval.

Lantana Nasir 1289 posts 0 comments

China records fewest daily COVID-19 cases in over a month

Finance Act: NCC to collaborate with Federal Inland Revenue Service